Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Visual hallucinations associated with Parkinson disease

J R Sanchez-Ramos1, R Ortoll, G W Paulson

  • 1Department of Neurology, University of Miami School of Medicine, Fla, USA.

Archives of Neurology
|December 1, 1996
PubMed
Summary

Dementia and older age are key predictors for developing visual hallucinations in Parkinson disease (PD). Managing medications like levodopa may help, but these factors highlight underlying predispositions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of neural markers in human umbilical cord blood.

Experimental neurology·2001
Same author

Restless legs syndrome. How to provide symptom relief with drug and nondrug therapies.

Geriatrics·2000
Same author

Traditional and complementary therapies in Parkinson's disease.

Advances in neurology·1999
Same author

Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording.

Journal of neurology, neurosurgery, and psychiatry·1999
Same author

Family with Pelizaeus-Merzbacher disease/X-linked spastic paraplegia and a nonsense mutation in exon 6 of the proteolipid protein gene.

American journal of medical genetics·1997
Same author

Lou Gehrig and amyotrophic lateral sclerosis. Is vitamin E to be revisited?

Archives of neurology·1997

Area of Science:

  • Neuroscience
  • Neurology
  • Geriatrics

Background:

  • Visual hallucinations are a common and distressing symptom in Parkinson disease (PD).
  • These hallucinations can significantly impact quality of life and are a frequent reason for long-term care placement.
  • The characteristics of PD-related hallucinations differ from those seen in other conditions like schizophrenia.

Purpose of the Study:

  • To identify predictive factors for the onset of hallucinations in patients with Parkinson disease.
  • To understand the relationship between various clinical and demographic variables and the occurrence of hallucinations.

Main Methods:

  • A cohort of 214 Parkinson disease patients was evaluated using standardized questionnaires and cognitive assessments.
  • Data collected included age, disease duration, medication history, and presence of psychological or sleep disorders.

Related Experiment Videos

  • Statistical analysis was performed to correlate these factors with the development of hallucinations.

    • Main Results:

    • Visual hallucinations were reported by 55 out of 214 patients.
    • Significant associations were found between hallucinations and dementia, advanced age, longer disease duration, depression history, and sleep disorders.

    Conclusions:

    • Dementia and increasing age are primary predisposing factors for visual hallucinations in Parkinson disease.
    • While medication adjustments (e.g., reducing levodopa) are part of management, these underlying factors are crucial.
    • The unique nature of PD-associated visual hallucinations warrants further investigation by neurologists and neuroscientists.